D47.02

Clinical Causes: Genetic mutations leading to abnormal mast cell proliferation Familial predisposition in some cases Unknown triggers in many instances Associated hematological non-mast cell lineage diseases (in certain types)

Key Symptoms: Flushing and skin rashes Itching and hives Abdominal pain, nausea, or diarrhea Low blood pressure or dizziness Anaphylactic reactions in severe cases Bone pain or fractures (especially in cases with bone involvement) Enlargement of organs like the spleen or liver Fatigue and weakness

Diagnosis Path: Diagnosis involves a combination of clinical evaluation and laboratory tests. A bone marrow biopsy is often performed to identify increased mast cells. Blood tests may reveal elevated levels of tryptase, an enzyme released by mast cells. Imaging studies can help assess organ involvement, and additional tests might be conducted to rule out associated hematological diseases. The classification of the disease depends on its presentation, ranging from indolent to aggressive forms.

Treatment Protocols: While some forms of systemic mastocytosis may not require treatment, management focuses on alleviating symptoms and preventing severe reactions. Options include antihistamines to control allergic symptoms, medications to stabilize mast cells, and epinephrine for emergency allergic reactions. For cases associated with other hematological disorders, targeted therapies may be necessary. Regular monitoring helps to track disease progression and adjust treatment plans accordingly.